Actieve functies van Patrik Ernfors
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Directeur/Bestuurslid | 01-01-2014 | - |
| Oprichter | 01-01-2014 | - |
Loopbaan van Patrik Ernfors
Eerdere bekende functies van Patrik Ernfors
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Global Genomics AB
 Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Hoofd Techniek/Wetenschap/O&O | 01-09-2000 | - |
Statistieken
Internationaal
| Zweden | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectoraal
| Commercial Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Global Genomics AB
Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Commercial Services |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Health Technology |
- Beurs
- Insiders
- Patrik Ernfors
- Ervaring
